Figure 2From: Revascularization and cardioprotective drug treatment in myocardial infarction patients: how do they impact on patients' survival when delivered as usual care Unadjusted Kaplan-Meier cardiovascular (CV) survival curves according to the number of cardiovascular drug classes claimed during index period among survivors at 30 days who did not receive a revascularization (n = 4473). * The curves are statistically different (p < .0001)Back to article page